|
Cys(Npys)-(Arg)9 is a synthetic cell-penetrating peptide (CPP) composed of a nona-arginine ((Arg)9) sequence and an N-terminal cysteine modified with a 3-nitro-2-pyridinesulfenyl (Npys) group. This dual-functional design enables both efficient intracellular delivery and highly selective thiol-reactive conjugation, making it a powerful platform for drug delivery and biomolecule conjugation applications. For related arginine-rich CPPs, see our R9 peptide.
Arginine-rich peptides such as (Arg)9 are among the most widely studied CPPs due to their strong ability to penetrate cell membranes. The high density of guanidinium groups promotes electrostatic interactions with negatively charged cell-surface components, including glycosaminoglycans and phospholipid bilayers, thereby enabling rapid cellular uptake across a wide range of mammalian cell types. Learn more about similar cell-penetrating peptides (CPPs) available at LifeTein.
The N-terminal Cys(Npys) group introduces an activated disulfide linker functionality. This moiety reacts selectively with free thiol groups (–SH) on cysteine residues of proteins, antibodies, or other peptides via thiol–disulfide exchange chemistry. The reaction releases 2-thiopyridone, allowing convenient monitoring of conjugation efficiency. This strategy enables site-specific conjugation under mild conditions without affecting other functional groups. For additional conjugation strategies, see our peptide conjugation services.
Applications in Cell-Penetrating Peptide (CPP) Delivery Systems
Cys(Npys)-(Arg)9 is widely used as a CPP delivery vector for transporting biomolecules into cells. Its combination of membrane translocation capability and disulfide-based conjugation makes it particularly valuable in:
- siRNA delivery and gene silencing applications
- Antisense oligonucleotide transport
- mRNA and CRISPR/Cas delivery research
- Protein and peptide intracellular delivery
- Nanoparticle and drug conjugate systems
siRNA Delivery and Gene Therapy Applications
Cell-penetrating peptides have been extensively investigated as non-viral vectors for siRNA delivery. The cationic arginine-rich domain facilitates binding and condensation of negatively charged nucleic acids, protecting them from degradation and promoting cellular uptake.
In Cys(Npys)-(Arg)9, the presence of a reducible disulfide linker allows covalent attachment of siRNA or other cargo molecules through thiol groups. Once internalized, the intracellular reducing environment (e.g., high glutathione concentration) cleaves the disulfide bond, enabling efficient release of the active payload in the cytosol. This mechanism enhances gene knockdown efficiency and improves delivery specificity. You may also explore our peptide–oligonucleotide conjugation services for custom delivery systems.
Disulfide Linker Strategy for Controlled Intracellular Release
The use of a disulfide linker is a well-established strategy in drug delivery systems. Disulfide bonds are stable in extracellular environments but are rapidly cleaved in the reducing intracellular space. This redox-responsive behavior enables:
- Stable circulation of peptide–cargo conjugates
- Selective intracellular release of therapeutics
- Reduced off-target effects and improved bioavailability
Cys(Npys)-(Arg)9 leverages this mechanism to function as a triggered delivery system for nucleic acids, proteins, and small molecules.
Thiol-Reactive Peptide Conjugation Platform
The Cys(Npys) group provides a highly efficient and selective method for thiol conjugation. This allows researchers to generate:
- Antibody–CPP conjugates
- Peptide–drug conjugates (PDCs)
- Protein–peptide delivery systems
- Targeted therapeutic constructs
This chemistry is particularly useful for site-specific conjugation, ensuring consistent orientation and activity of the conjugated biomolecule. For fluorescent tracking applications, consider combining with FITC-labeled peptides.
Applications in Antibody-Mediated Delivery
Cys(Npys)-(Arg)9 has been used in antibody-mediated siRNA delivery and targeted therapeutic systems. By conjugating CPPs to antibodies through cysteine residues, researchers can achieve both cell specificity and enhanced intracellular delivery. This approach has been explored in antiviral strategies, including the development of anti-HIV therapeutics.
Advantages of Cys(Npys)-(Arg)9
- Efficient cell-penetrating peptide (CPP) for intracellular delivery
- Selective thiol-reactive conjugation via Npys chemistry
- Redox-sensitive disulfide linker for controlled release
- Compatible with siRNA, proteins, antibodies, and small molecules
- Widely used in gene therapy and drug delivery research
| 